RESOURCES

Download or order resources to
help patients with diabetic retinal disease

your cart 0

For You and
Your Staff

Resources to help you understand the different stages of Diabetic Retinopathy (DR) and the referral guidelines.

Diabetic Retinopathy (DR) Patient
Identification and Referral Guide

Diabetic Retinopathy Patient Identification and Referral Guide PDF download.

A guide that describes the clinical features of DR at various stages and includes the current referral guidelines from the American Optometric Association (AOA). This tool will help facilitate early detection and timely referral to a retina specialist when appropriate.

Diabetic Retinopathy (DR) Quick
Reference Guide

Diabetic Retinopathy (DR) Quick Reference Guide PDF download

A handy reference guide to help identify the stages of DR and presence of DME. It includes an overview of the Early Treatment Diabetic Retinopathy Study–Diabetic Retinopathy Severity Scale (ETDRS-DRSS), with corresponding images and labeled descriptions.

DR In-Office Patient Education Slider

A tool to help patients understand the different stages of DR and the progression of anatomic changes.

DR In-Office Poster: English

Diabetic RetinopathyIn-Office Poster PDF download

A poster to help patients understand the different stages of DR, as well as the importance of caring for their eyes by talking with their eye doctor and receiving a timely referral to a retina specialist when appropriate.

DR In-Office Poster: Spanish

A Spanish-language poster to help patients understand the different stages of DR, as well as the importance of caring for their eyes by talking with their eye doctor and receiving a timely referral to a retina specialist when appropriate.


Patient Education Resources

Resources to help patients and their families and caregivers understand diabetic retinal disease.

Amsler Grid

Amsler Grid PDF download

A printable Amsler Grid with patient-friendly instructions on how to use the tool to monitor vision. The Amsler Grid is a remote vision monitoring tool to help patients monitor changes in vision at home, in between treatments.

DME Patient Brochure: English

DME Patient Brochure - English PDF download

A patient education brochure that explains what DME is, who it affects, how it can affect vision, and treatment with EYLEA.

DME Patient Brochure: Spanish

DME Patient Brochure - Spanish

A Spanish-language patient education brochure that explains what DME is, who it affects, how it can affect vision, and treatment with EYLEA.

Doctor Discussion Guide

Doctor Discussion Guide

A guide to help patients ask questions during their first eye care appointment.

DR Patient Brochure: English

Diabetic RetinopathyIn-Office Poster PDF download

A patient education brochure that explains what DR is, who it affects, how it can affect vision and progress, and treatment with EYLEA.

DR Patient Brochure: Spanish

A Spanish-language patient education brochure that explains what DR is, who it affects, how it can affect vision and progress, and treatment with EYLEA.

Patient Tearsheet: English

Diabetic Retinopathy (DR) Patient Tearsheet PDF download

A take-home tearsheet for patients that reinforces the importance of early disease detection, timely treatment, and follow-up care.

Patient Tearsheet: Spanish

Diabetic Retinopathy (DR) Patient Tearsheet PDF download

A Spanish-language take-home tearsheet for patients that reinforces the importance of early disease detection, timely treatment, and follow-up care.

EYLEA Prescribing Information

EYLEA USPI August 2019 PDF download

Full Prescribing Information for EYLEA.

Diabetic Eye Disease, Episode 1: Current Landscape and Unmet Needs

EYLEA USPI August 2019 PDF download

The first audio article in this 4-part series looks at the current landscape and unmet needs in the management of DR and DME, focusing on the goals of effective care in patients with diabetic retinal disease—what currently works in practice and what can be improved.

Diabetic Eye Disease, Episode 2: Shifting the Paradigm in Management

EYLEA USPI August 2019 PDF download

The second audio article in this 4-part series revolves around how the paradigm in management can be shifted to establish that successful treatment also includes early identification of disease process, appropriate timing of referral, and improved provider and patient awareness.

Diabetic Eye Disease, Episode 3: Advances in the Treatment of DME and DR

EYLEA USPI August 2019 PDF download

The third audio article in this 4-part series includes a discussion between an optometrist and a retina specialist, using existing data and their own experiences, looking at anti-VEGF therapy within clinical practice—the appropriate patient types, its use with other modalities—and its role as the standard of care in diabetic retinal disease.

Diabetic Eye Disease, Episode 4: Evolving Partnership and Collaboration in Diabetic Eye Disease

EYLEA USPI August 2019 PDF download

This round table provides a summary of the previous audio articles in this series, with a focus on early intervention, patient communication, and collaboration between optometrists and retina specialists in the treatment of DR and DME.

Modern Treatment Approaches for the Management of Wet AMD

EYLEA USPI August 2019 PDF download

This audio article includes a discussion around the advancements in the Wet AMD treatment landscape and the panel's experience with anti-VEGF use in the clinical setting. The panel members include Dr John Kitchens, Dr Christina Weng, Dr Carl Danzig, and Dr Elias Reichel.

See More Important Safety Information and Indications
  • CONTRAINDICATIONS: EYLEA® (aflibercept) Injection is contraindicated in patients with ocular or periocular infections, active intraocular inflammation, or known hypersensitivity to aflibercept or to any of the excipients in EYLEA.
Important Safety Information and Indications INDICATIONS

EYLEA® (aflibercept) Injection 2 mg (0.05 mL) is indicated for the treatment of patients with Neovascular (Wet) Age-related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion (RVO), Diabetic Macular Edema (DME), and Diabetic Retinopathy (DR).

Please see the full Prescribing Information for EYLEA.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

The information provided in this site is intended only for healthcare professionals in the United States. The products discussed herein may have different product labeling in different countries.